Rick Pauls | President, Chief Executive Officer |
Scott Kellen | Chief Financial Officer |
Harry Alcorn | Chief Medical Officer |
Alexander Nowak | Craig-Hallum Capital Group |
Thomas Flaten | Lake Street Capital Markets |
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2020 Financial Results Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investors section.
Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including the factors that could cause actual results to differ from projected results appears in the section entitled Cautionary Statement Note regarding forward-looking statements in the company's press release issued yesterday and under the heading Risk Factors in DiaMedica's previously filed annual reports on Form 10-K.